Global Head, Biopharmaceuticals
In his role as Sandoz Global Head, Biopharmaceuticals, Pierre Bourdage leads the organization that is responsible for the strategy and commercialization of biopharmaceuticals and represents the Biopharmaceuticals unit as member of the Sandoz Executive Committee. Sandoz has eight biosimilars approved in total, has launched three biosimilars in 2018 and continues to invest and expand a leading biosimilar pipeline.
Pierre brings considerable experience in launch excellence and team leadership as well as brand and franchise management with over 16 years in the pharmaceutical and healthcare industry. He enjoys leading collaborative and externally oriented teams, and is passionate about the Biopharmaceuticals business unit purpose in helping patients and healthcare systems improve access and affordability to biologic medicines.
Prior to joining Sandoz Pierre worked within Novartis owned companies Alcon and Novartis Pharmaceuticals where he held numerous country and global roles over a 16-year period. This career path has allowed Pierre to build experience in innovative pharmaceuticals, medical devices and generics. He has deep therapeutic area experience spanning immunology, ophthalmology, cardiology, dermatology and neuroscience